175 related articles for article (PubMed ID: 27852542)
21. Autoimmune gastritis: relationships with anemia and Helicobacter pylori status.
Villanacci V; Casella G; Lanzarotto F; Di Bella C; Sidoni A; Cadei M; Salviato T; Dore MP; Bassotti G
Scand J Gastroenterol; 2017; 52(6-7):674-677. PubMed ID: 28276835
[TBL] [Abstract][Full Text] [Related]
22. Gastric cancer in autoimmune gastritis: A case-control study from the German centers of the staR project on gastric cancer research.
Weise F; Vieth M; Reinhold D; Haybaeck J; Goni E; Lippert H; Ridwelski K; Lingohr P; Schildberg C; Vassos N; Kruschewski M; Krasniuk I; Grimminger PP; Waidmann O; Peitz U; Veits L; Kreuser N; Lang H; Bruns C; Moehler M; Lordick F; Gockel I; Schumacher J; Malfertheiner P; Venerito M
United European Gastroenterol J; 2020 Mar; 8(2):175-184. PubMed ID: 32213076
[TBL] [Abstract][Full Text] [Related]
23. The gastric mucosa 25 years after proximal gastric vagotomy.
Sagatun L; Jianu CS; Fossmark R; Mårvik R; Nordrum IS; Waldum HL
Scand J Gastroenterol; 2014 Oct; 49(10):1173-80. PubMed ID: 25157752
[TBL] [Abstract][Full Text] [Related]
24. [Influence of long-term gastric acid suppression therapy on the expression of serum gastrin, chromogranin A, and ghrelin].
Kim BW; Lee BI; Kim HK; Cho YS; Chae HS; Lee HK; Kim HJ; Han SW
Korean J Gastroenterol; 2009 Feb; 53(2):84-9. PubMed ID: 19237833
[TBL] [Abstract][Full Text] [Related]
25. [Type 1 carcinoids and ECL-cell hyperplasia of the gastric mucosa].
Stachura T; Strzałka M; Bolt L
Przegl Lek; 2003; 60(12):782-8. PubMed ID: 15058016
[TBL] [Abstract][Full Text] [Related]
26. Gastric carcinoids after long-term use of a proton pump inhibitor.
Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
[TBL] [Abstract][Full Text] [Related]
27. Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas.
Bashir S; Gibril F; Ojeaburu JV; Asgharian B; Entsuah LK; Ferraro G; Crafa P; Bordi C; Jensen RT
Aliment Pharmacol Ther; 2002 Jul; 16(7):1367-82. PubMed ID: 12144588
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of gastrin levels for the diagnosis of gastric enterochromaffin-like cell hyperplasia in patients with Hashimoto's thyroiditis.
Nicolaou A; Thomas D; Alexandraki KI; Sougioultzis S; Tsolakis AV; Kaltsas G
Neuroendocrinology; 2014; 99(2):118-22. PubMed ID: 24776735
[TBL] [Abstract][Full Text] [Related]
29. Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia.
Hirschowitz BI; Worthington J; Mohnen J; Haber M
Aliment Pharmacol Ther; 2007 Sep; 26(6):869-78. PubMed ID: 17767471
[TBL] [Abstract][Full Text] [Related]
30. Antrectomy for multicentric, argyrophil gastric carcinoids: a preliminary report.
Eckhauser FE; Lloyd RV; Thompson NW; Raper SE; Vinik AI
Surgery; 1988 Dec; 104(6):1046-53. PubMed ID: 3194832
[TBL] [Abstract][Full Text] [Related]
31. [Autoimmune metaplastic atrophic gastritis, G cell hyperplasia and neuroendocrine tumor of stomach].
Chen G; Huang S
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):34-5. PubMed ID: 24713247
[No Abstract] [Full Text] [Related]
32. Marked increase in fundic mucosal histidine decarboxylase activity in a patient with H+,K(+)-ATPase antibody-positive autoimmune gastritis.
Miyazaki Y; Shinomura Y; Murayama Y; Imamura I; Fukui H; Maeda M; Futai M; Matsuzawa Y
Intern Med; 1993 Jul; 32(7):602-6. PubMed ID: 8286844
[TBL] [Abstract][Full Text] [Related]
33. Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs.
Campana D; Nori F; Pezzilli R; Piscitelli L; Santini D; Brocchi E; Corinaldesi R; Tomassetti P
Endocr Relat Cancer; 2008 Mar; 15(1):337-42. PubMed ID: 18310299
[TBL] [Abstract][Full Text] [Related]
34. Argyrophil cell hyperplasia of fundic mucosa in patients with chronic atrophic gastritis.
Bordi C; Pilato F; Carfagna G; Ferrari C; D'Adda T; Sivelli R; Bertelé A; Missale G
Digestion; 1986; 35 Suppl 1():130-43. PubMed ID: 3792670
[TBL] [Abstract][Full Text] [Related]
35. Plasma ghrelin concentrations in type 1 diabetic patients with autoimmune atrophic gastritis.
Alonso N; Granada ML; Salinas I; Reverter JL; Flores L; Ojanguren I; Martínez-Cáceres EM; Sanmartí A
Eur J Endocrinol; 2007 Dec; 157(6):763-9. PubMed ID: 18057384
[TBL] [Abstract][Full Text] [Related]
36. Assessment of Gastric Emptying in Patients with Autoimmune Gastritis.
Kalkan Ç; Soykan I; Soydal Ç; Özkan E; Kalkan E
Dig Dis Sci; 2016 Jun; 61(6):1597-602. PubMed ID: 26725066
[TBL] [Abstract][Full Text] [Related]
37. Treatment of ECL cell carcinoids with octreotide LAR.
Fykse V; Sandvik AK; Qvigstad G; Falkmer SE; Syversen U; Waldum HL
Scand J Gastroenterol; 2004 Jul; 39(7):621-8. PubMed ID: 15370681
[TBL] [Abstract][Full Text] [Related]
38. Mixed endocrine gastric tumors associated with hypergastrinemia of antral origin.
Larsson LI; Rehfeld JF; Stockbrügger R; Blohme G; Schöön IM; Lundqvist G; Kindblom LG; Säve-Söderberg J; Grimelius L; Olbe L
Am J Pathol; 1978 Oct; 93(1):53-68. PubMed ID: 696807
[TBL] [Abstract][Full Text] [Related]
39. Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.
Moore AR; Boyce M; Steele IA; Campbell F; Varro A; Pritchard DM
PLoS One; 2013; 8(10):e76462. PubMed ID: 24098507
[TBL] [Abstract][Full Text] [Related]
40. Gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type A.
Müller J; Kirchner T; Müller-Hermelink HK
Am J Surg Pathol; 1987 Dec; 11(12):909-17. PubMed ID: 3318512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
